CutoSense Ltd. is specialized in developing novel wound assessment and treatment systems. Our first product the WoundWatch® is intended for assessment and treatment of hard-to-heal wounds. The measurements provide reliable and repeatable quantitative results without the need of removing the dressings thus improving the quality of life of the patient and providing significant time savings for the healthcare professionals (i.e. 80 minutes/wound/week). The WoundWatch® is currently in prototype stage, thus not yet commercially available. Our target for CE certification is Q1/2019.
Our clear vision is to develop innovative solutions assisting healthcare providers and improving patients’ quality of life.